PTGDR2 and chronic obstructive pulmonary disease: The prominent role of CRTH2 in the lung prompted investigations to evaluate the potential of the CRTH2 antagonist AZ11805131 in tobacco smoke-induced airway inflammation, modelling chronic obstructive pulmonary disease (COPD) [61].